What is the address of DR.S. GYSENBERGS,GENEESHEER?

The registered office of DR.S. GYSENBERGS,GENEESHEER is located at Venushoek 54, 2590 Berlaar.

Is DR.S. GYSENBERGS,GENEESHEER still active?

Yes. According to the CBE (16 September 2026) DR.S. GYSENBERGS,GENEESHEER is active, legal situation “Normale toestand”, started on 6 November 2006.

Is DR.S. GYSENBERGS,GENEESHEER registered on Peppol?

Yes, DR.S. GYSENBERGS,GENEESHEER is registered on the Peppol network with ID 0208:0885076203.

What is the enterprise number of DR.S. GYSENBERGS,GENEESHEER?

The enterprise number of DR.S. GYSENBERGS,GENEESHEER is BE0885076203.

When was DR.S. GYSENBERGS,GENEESHEER founded?

DR.S. GYSENBERGS,GENEESHEER was founded on 6 November 2006.

Who are the directors of DR.S. GYSENBERGS,GENEESHEER?

According to the 2025 annual accounts, the directors of DR.S. GYSENBERGS,GENEESHEER are: Stijn Gysenbergs.

Is DR.S. GYSENBERGS,GENEESHEER a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 November 2006; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR.S. GYSENBERGS,GENEESHEER make in 2025?

DR.S. GYSENBERGS,GENEESHEER posted a profit after taxes of € 103,077 in financial year 2025.

What is the revenue of DR.S. GYSENBERGS,GENEESHEER?

As a small company, DR.S. GYSENBERGS,GENEESHEER is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 162,455.

DR.S. GYSENBERGS,GENEESHEER (Private Limited) - Berlaar

Dossier DR.S. GYSENBERGS,GENEESHEER, printed on 16 September 2026 from databakkes.be/en/0885076203/dr-s-gysenbergs-geneesheer. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR.S. GYSENBERGS,GENEESHEER from Berlaar, company number BE0885076203, closed financial year 2025 with a result of € 103,077 after tax. For that financial year DR.S. GYSENBERGS,GENEESHEER recorded a gross margin of € 162,455 and equity of € 488,573. Compared with financial year 2024, the result moved from € 76,206 to € 103,077. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 18, 2026.

What it is worth Growing

€ 488,573

▲ 6% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 103,077

▲ 35% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 185,855

▲ 36% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 74,913 paid out

73 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 39,049

▼ 26% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Taxes

€ 7,735

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 115,731 Gross margin 2022: € 115,731 First fiscal year in the series	€ 110,470 Gross margin 2023: € 110,470 ▼ 5% vs 2022 (€ 115,731) Unfavourable step	€ 122,281 Gross margin 2024: € 122,281 ▲ 11% vs 2023 (€ 110,470) Favourable step	€ 162,455 Gross margin 2025: € 162,455 ▲ 33% vs 2024 (€ 122,281) Favourable step	▲ 33%
Profit after taxes	€ 69,639 Profit after taxes 2022: € 69,639 First fiscal year in the series	€ 73,378 Profit after taxes 2023: € 73,378 ▲ 5% vs 2022 (€ 69,639) Favourable step	€ 76,206 Profit after taxes 2024: € 76,206 ▲ 4% vs 2023 (€ 73,378) Favourable step	€ 103,077 Profit after taxes 2025: € 103,077 ▲ 35% vs 2024 (€ 76,206) Favourable step	▲ 35%
Equity	€ 432,326 Equity 2022: € 432,326 First fiscal year in the series	€ 447,529 Equity 2023: € 447,529 ▲ 4% vs 2022 (€ 432,326) Favourable step	€ 460,409 Equity 2024: € 460,409 ▲ 3% vs 2023 (€ 447,529) Favourable step	€ 488,573 Equity 2025: € 488,573 ▲ 6% vs 2024 (€ 460,409) Favourable step	▲ 6%
Total debts	€ 3,892 Total debts 2022: € 3,892 First fiscal year in the series	€ 8,008 Total debts 2023: € 8,008 ▲ 106% vs 2022 (€ 3,892) Unfavourable step	€ 19,667 Total debts 2024: € 19,667 ▲ 146% vs 2023 (€ 8,008) Unfavourable step	€ 27,734 Total debts 2025: € 27,734 ▲ 41% vs 2024 (€ 19,667) Unfavourable step	▲ 41%
Cash	€ 215,308 Cash 2022: € 215,308 First fiscal year in the series	€ 49,681 Cash 2023: € 49,681 ▼ 77% vs 2022 (€ 215,308) Unfavourable step	€ 137,016 Cash 2024: € 137,016 ▲ 176% vs 2023 (€ 49,681) Favourable step	€ 185,855 Cash 2025: € 185,855 ▲ 36% vs 2024 (€ 137,016) Favourable step	▲ 36%
Land & buildings	€ 1,992 Land & buildings 2022: € 1,992 First fiscal year in the series	-	-	-
Retained profit	€ 419,926 Retained profit 2022: € 419,926 First fiscal year in the series	€ 433,269 Retained profit 2023: € 433,269 ▲ 3% vs 2022 (€ 419,926) Favourable step	€ 446,149 Retained profit 2024: € 446,149 ▲ 3% vs 2023 (€ 433,269) Favourable step	€ 474,313 Retained profit 2025: € 474,313 ▲ 6% vs 2024 (€ 446,149) Favourable step	▲ 6%
Dividend	€ 52,456 Dividend 2022: € 52,456 First fiscal year in the series	€ 58,175 Dividend 2023: € 58,175 ▲ 11% vs 2022 (€ 52,456) Unchanged	€ 63,326 Dividend 2024: € 63,326 ▲ 9% vs 2023 (€ 58,175) Unchanged	€ 74,913 Dividend 2025: € 74,913 ▲ 18% vs 2024 (€ 63,326) Unchanged	▲ 18%
Balance sheet total	€ 436,218 Balance sheet total 2022: € 436,218 First fiscal year in the series	€ 455,537 Balance sheet total 2023: € 455,537 ▲ 4% vs 2022 (€ 436,218) Unchanged	€ 480,076 Balance sheet total 2024: € 480,076 ▲ 5% vs 2023 (€ 455,537) Unchanged	€ 516,307 Balance sheet total 2025: € 516,307 ▲ 8% vs 2024 (€ 480,076) Unchanged	▲ 8%

Key figures of DR.S. GYSENBERGS,GENEESHEER, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR.S. GYSENBERGS,GENEESHEER?

What happened at DR.S. GYSENBERGS,GENEESHEER in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 18, 2026 New annual accounts for financial year 2025: profit of € 103,077 (▲ 35% vs 2024). Source: NBB ↗
Nov 6, 2006 New establishment in Berlaar. KBO
Nov 6, 2006 Start of the company according to the CBE. KBO

In short

From € 69,639 profit in 2022 to € 103,077 profit in 2025.

Paid € 141,617 in corporate taxes since 2022.

Best year ever: 2025, with € 103,077 profit.

Paid out € 248,870 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR.S. GYSENBERGS,GENEESHEER? We notify you, reason included.

Follow DR.S. GYSENBERGS,GENEESHEER

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Stijn Gysenbergs

DR.S. GYSENBERGS,GENEESHEER

Behind DR.S. GYSENBERGS,GENEESHEER is Stijn Gysenbergs.

See the full network in the app

Directors

According to the 2025 annual accounts

Stijn Gysenbergs

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Venushoek 54

2590 Berlaar

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0885.076.203
VAT number: BE 0885.076.203
Registered office: Venushoek 54, 2590 Berlaar
Names & denominations: DR.S. GYSENBERGS,GENEESHEER
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 6 November 2006
Peppol: Active · Active since 23 Apr 2025

View on CBE Public ↗ Annual accounts (NBB) ↗